Yael Hayon - VP, Research & Development at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Research & Development
Issuer Symbol
PLX on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Yael Hayon since 11 Mar 2025

Holdings reported by Yael Hayon for Protalix BioTherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35,115 $49,512 $1.41 15 Aug 2023 By Trust
Stock Options (Right to Buy) 35,115 15 Aug 2023 Direct Common Stock

Transactions reported by Yael Hayon for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.